CLINICAL_TRIALS
trial_result
· 2018-08-16
Clinical Trial Update: PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial update for PF-00299804 in adults with relapsed/recurrent glioblastoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma, GBM | Phase 2 | Status: COMPLETED